Workplace-Related Interpersonal Group Psychotherapy to Improve Life at Work in Individuals With Major Depressive Disorders: A Randomized Interventional Pilot Study by Niedermoser, Daryl Wayne et al.
Frontiers in Psychiatry | www.frontiersin.or
Edited by:
Takeshi Terao,
Oita University, Japan
Reviewed by:
Sam Cortese,
University of Southampton,
United Kingdom
Roumen Kirov,
Institute of Neurobiology
(BAS), Bulgaria
*Correspondence:
Daryl Wayne Niedermoser
daryl.niedermoser@upk.ch
Specialty section:
This article was submitted to
Psychological Therapies,
a section of the journal
Frontiers in Psychiatry
Received: 31 October 2019
Accepted: 21 February 2020
Published: 17 March 2020
Citation:
Niedermoser DW, Kalak N,
Kiyhankhadiv A, Brand S, Walter C,
Schweinfurth N and Lang UE (2020)
Workplace-Related Interpersonal
Group Psychotherapy to Improve Life
at Work in Individuals With Major
Depressive Disorders: A Randomized
Interventional Pilot Study.
Front. Psychiatry 11:168.
doi: 10.3389/fpsyt.2020.00168
ORIGINAL RESEARCH
published: 17 March 2020
doi: 10.3389/fpsyt.2020.00168Workplace-Related Interpersonal
Group Psychotherapy to Improve Life
at Work in Individuals With Major
Depressive Disorders: A Randomized
Interventional Pilot Study
Daryl Wayne Niedermoser1,2*, Nadeem Kalak1, Anna Kiyhankhadiv1, Serge Brand1,3,4,5,6,
Corinna Walter1, Nina Schweinfurth1 and Undine E. Lang1
1 University Psychiatric Clinics (UPK), University of Basel, Basel, Switzerland, 2 Departement of Business, Kalaidos University
of Applied Sciences, Zurich, Switzerland, 3 Substance Abuse Prevention Research Center, Kermanshah University of Medical
Sciences, Kermanshah, Iran, 4 Department of Sport, Exercise and Health, University of Basel, Basel, Switzerland, 5 School of
Medicine, Tehran University of Medical Sciences, Tehran, Iran, 6 Sleep Disorders Research Center, Kermanshah University of
Medical Sciences, Kermanshah, Iran
Objectives: Individuals suffering from major depressive disorder (MDD) often report
workplace-related stress as the major cause of their disorder. Accordingly, workplace-
related stress was established as a fifth psychosocial problem area of Interpersonal
Psychotherapy (workplace-related Interpersonal Psychotherapy, W-IPT). The aim of the
study was to investigate the influence of W-IPT on depressive symptoms and on
workplace-related issues in individuals with MDD compared to a treatment-as-usual
(TAU) condition.
Methods: A total of 27 individuals with MDD (mean age = 43 years, 48% males) were
randomly assigned either to eight weekly group sessions of W-IPT or to the TAU
condition. At baseline, 8 weeks later at the end of the intervention, and 20 weeks later
at follow-up, the Hamilton Rating Scale for Depression was conducted. In addition, the
participants completed the Beck Depression Inventory, the Work Ability Index (WAI), the
Return to Work Attitude (RTW-SE), and the Insomnia Severity Index (ISI).
Results: Symptoms of depression in experts' ratings as well as in self-rated ratings
decreased over time, but more so in the W-IPT condition compared to the TAU condition
[experts rating: large effect size (d = 1.25) and self-assessment: large effect sizes (d =
0.94)]. The subjective ability to work (WAI) [medium effect size (d = 0.68)], self-efficacy to
returning to work RTW-SE [medium effect size (d = 0.57)], and subjective symptoms of
insomnia (ISI) [large effect size (d = 1.15)] increased over time, but again more so in the W-
IPT condition compared to the TAU condition. The effects of the intervention remained
stable from the end of the intervention to follow-up.
Conclusions: The pattern of results of this pilot study suggests that a newly established
fifth IPT focus on workplace-related stress appeared to be particularly efficient ing March 2020 | Volume 11 | Article 1681
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Frontiers in Psychiatry | www.frontiersin.oindividuals with MDD due to work-related stress in reducing depressive symptoms and
reducing sleep complaints as well as in improving occupational outcomes.Keywords: workplace-related stress, interpersonal psychotherapy, depression, ability to work, self-efficacy to
returning to work, sleepINTRODUCTION
Major depressive disorder (MDD) is a common and disabling
psychiatric disorder associated with an increase in disability and
mortality (1). Based on the data using the disability-adjusted-life-
years to assess “the sum years lost due to premature mortality
and years lived with disability adjusted for severity,”Murray and
Lopez (2) estimated that MDD will be the third leading cause of
burden worldwide by 2020. By contrast, Jorm et al. (3) claimed
that the epidemiologic prevalence rates of MDD did not increase
within the 30 years, while the social awareness of depression did.
Standard treatments of moderate and severe MDD consist
mainly on the administration of antidepressants, i.e., serotonin-
reuptake inhibitors. More recent reviews and meta-analyses
questioned the efficacy of antidepressants and the unpleasant
side effects might be a reason why people with MDD often quit
antidepressant medication (4–8). Other evidence-based
treatment options are neuromodulation (9–11), cognitive–
behavioral interventions (12, 13), or regular physical activity
(14–17).
Treatment guidelines (AWMF, NICE) recommend
antidepressants and/or psychotherapy to treat moderate and
severe MDD. Individuals with major depressive disorders often
report stressful issues related to the workplace. Job strain, low job
control, low social support, high psychological demands, effort–
reward imbalance, and high job insecurity were confirmed as
predictors particularly for depression (18–23). Several studies
(24–27) show that, compared to healthy individuals, individuals
with MDD are at an increased risk to lose their current job
position (24, 25, 27), to have more difficulties to go back to their
workplace (24, 25, 27), to find a new job, once they have been
dismissed, and to keep their job position, when they return to
their job after a period of illness-related unemployment.
Furthermore, data on health costs show that, compared to an
accident-related absence from work, depression-related absence
from work cause higher economic burden for the individual (25,
27), the employer (27–29), and the public (24, 26, 27, 30). In
addition, losing a job position or experiencing difficulties to go
back to work turned out to be a risk factor for further relapses of
MDD (24).
In this context, specific interventions to reduce workplace-
related stress in individuals with MDD might both reduce the
economic costs for the public and the burden for the individual
(24, 26, 27, 29, 30).
Here we present the influence of the newly developed
workplace-related Interpersonal Psychotherapy (W-IPT) which
is a specific intervention to influence the workplace-related
dimensions of symptoms of individuals with MDD. The original
IPT concept was developed as a brief psychotherapeutic treatment
aiming at the symptoms of an acute depressive disorder andrg 2current interpersonal problems and its effectiveness for the
treatment of MDD has been widely demonstrated in numerous
controlled trials [cf. meta-analysis from Cuijpers et al. (31)].
The W-IPT focuses on issues occurring in the context of the
work role (32) such as social and interpersonal problems at work,
mobbing, interpersonal conflicts, role transition, role confusion,
burnout, boreout, job strain, low social support, effort–reward
imbalance, job demand–control imbalance, and work–
life imbalance.
The following three hypotheses and one research question
were formulated and each of these is considered in turn. First,
following Knekt et al. (33), Hange et al. (34), and Hallgren et al.
(35), we expect that, compared to the TAU condition, the
workplace-related dimensions of (a) the ability to work and (b)
the self-efficacy in returning to work increased over time. The
second hypothesis was in the context of empirical evidence (12,
31, 36, 37). We expect that the W-IPT treatment has positive
effects on depressive symptoms when compared to the TAU
condition. The symptoms of depression will improve in the
experts' rating and in the self-rating. Following the second
hypothesis and combining it with those of Santor and
Kusumakar (38) and Lemmens et al. (37), we formulated the
following exploratory research question. If there is a benefit in
the W-IPT group, is the effect stable over a 3-month period
measured at follow-up? Third, following Göder et al. (39) and
Dombrovski et al. (40), we expected that, compared to the TAU
condition, the W-IPT treatment will decrease the symptoms
of insomnia.METHOD
Procedure
We conducted a monocentric, randomized, controlled trial
comparing W-IPT versus TAU condition in a group format in
outpatients with major depression related to workplace-related
issues between April 2018 and September 2019. The regional
ethics commission (Ethikkommission Nordwest- und
Zentralschweiz) approved the study (application number 2017-
01-489). The eligible patients were fully informed about the
study and signed the written informed consent at the first
meeting. Moreover, all procedures were in line with the ethical
standards of the Declaration of Helsinki (41) and its later
amendments and with the ethical code of conduct of the
American Psychological Association.
There was a total of one individual screening before the
baseline and three data collections. The Hamilton Experts'
Rating Scale for Depression (HRSD-24) was conducted in the
screening part before the baseline as an information guide
whether to include or exclude participants and to train (andMarch 2020 | Volume 11 | Article 168
Niedermoser et al. Workplace-Related Interpersonal Group Psychotherapyexplain) the questions. At baseline, the HRSD-24 was conducted
and all questionnaires were filled out by the participants. The
same procedure was applied at the last meeting (8 weeks after the
start of the intervention) and at 12 weeks after the end of
the treatment (follow-up at 20 weeks after randomization) (see
Figure 1 and Table 1).
Sample
In-patients and out-patients were recruited through either a
media announcement or a licensed practitioner. A total of 56
interested participants were clarified after a quick telephone/
e-mail screening. They were invited to an extended interview
[interview, informed consent, Structured Clinical Interview
for Disorders on the axis I (SCID-I), and HRSD-24]. A total of
28 (50.0%) of the 56 patients fulfilled the inclusion criteria.
The inclusion criteria were (1) being between 18 and 65 years
of age, (2) major depressive disorder (SCID-I), (3) issues at or
with the workplace (e.g., mobbing, effort–reward imbalance,Frontiers in Psychiatry | www.frontiersin.org 3and few social support), (4) fluent in German, (5) signed
written informed consent, (6) complying with the study
conditions, and (7) no or stable psychopharmacological and
psychotherapeutic treatments 4 weeks before the study and
throughout the study. The exclusion criteria were (1) HRSD-
24 < 18), (2) acute suicidality, (3) psychotic symptoms or
bipolar disorder, (4) primary diagnosis of another mental
illness, (5) substance use disorder, (6) personality disorder,
and (7) applied (or already accepted) disability pension.
Of the 28 eligible participants, there was one non-starter and
27 started (mean age = 43 years, SD = 10.2, 48% males)
participating in the present study. There were 14 participants
assigned to the W-IPT and 13 to the TAU condition (see
Figure 1, CONSORT flow chart).
Randomization
A psychologist not otherwise involved in the study performed
the randomization. A total of 15 blue and 15 red chips were putFIGURE 1 | CONSORT flow diagram.March 2020 | Volume 11 | Article 168
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chip and assigned the participant to the study condition. Then,
the chip was put aside. To make sure that the blinding procedure
is still clear, the participants were informed not to tell the
psychologist anything about their treatment. After having
taken part in the TAU condition, the participants were given
the option to participate in a W-IPT group. The two groups did
not differ as regards to age range, gender, civil status,
employment, highest educational qualifications, antidepressants
use, or in- and outpatient (see Table 2).
Measurements
To test our hypothesis, we used internationally recognized and
well-established questionnaires in German. For several
hypotheses, we used a few less-known questionnaires. These
have been translated and translated back to ensure that the
content is queried correctly. Mental disorders were assessed by
means of the SCID-I based on DSM-IV (42, 43).
Depression Questionnaires
Experts’ Rating
The Hamilton Rating Scale for Depression (44) consisted of 24
items, asking on low mood, suicidality, irritability, tension,
loss of appetite, loss of interests, and other somatic symptoms.
Answers were given on rating scales differing from three-,
four-, or five-point ratings. Higher sum scores reflect more
marked depressive symptoms. Additionally, the scores were
categorized as follows: 0–7, no depressive symptom/Frontiers in Psychiatry | www.frontiersin.org 4remission; 8–17, mild; 18–24, moderate; 25 and more, severe
depressive disorder (Cronbach's alpha = 0.71).Self-Rating
The Beck's Depression Inventory (BDI-II) examines the
depressive symptomatology from a self-perspective (45). The
BDI-II is a widely established self-assessment tool with 21 items.
It captures the affective, cognitive, and behavioral dimensions as
well as the somatic symptoms of depression. The test quality
criteria, such as internal consistency, validity, and test–retest
reliability, are most satisfactory in both clinical and non-clinical
subjects (46) (Cronbach's alpha = 0.89).Workplace-Related Questionnaires
The Work Ability Index (47) is a measurement tool that uses a
questionnaire to calculate an index value for assessing the ability
to work. This index value indicates the extent to which an
employee is able to carry out his/her work on the basis of his/
her personal circumstances and existing working conditions
(Cronbach's alpha= 0.70).
Return to Work Self-Efficacy (RTW-SE) is the belief in one's
own ability to meet the demands required to return to work. The
“return to work attitude” questionnaire (48) contains 11
questions on self-efficacy in managing demands at work
(Cronbach's alpha = 0.66).Subjective Sleep Quality
Sleep Complaints Measured With the Insomnia
Severity Index
The questionnaire is in part in line with the DSM-IV insomnia
criteria and measures current perception (within the last 2
weeks) in terms of symptom severity, stress, and impairment.
These include severity of onset and persistence of sleep (mid-
morning and early morning wake disorder), satisfaction with the
current sleep pattern, daily life impairment, occurrence of
impairments due to sleep problem, and concern about sleep
disorders [see Morin et al. (49) and Gerber et al. (50)]
(Cronbach's alpha = 0.77).TABLE 2 | Sociodemographic and illness-related information, separately for participants in W-IPT and TAU condition.
Groups Statistics
W-IPT TAU
N 14 13
Age range in years 24–55 28–55
Age in years M (SD) 40.86 (11.29) 45.77 (8.438) t(25) = -1.279, p = .213
Gender (female/male) 7/7 7/6 X2(N=27 df = 1) = 0.04, p = .84
Civil status (single/married) 10/4 9/4 X2(N=27, df = 1) = 0.16, p = .90
Current job position (yes/no) 11/3 9/4 X2(N=27, df = 1) = 0.31, p = .58
Educational level (high school/diploma/university degree) 1/6/7 1/5/7 X2(N=27, df = 2) = 0.05, p = .97
Antidepressants (yes/no) 10/4 7/6 X2(N=27, df = 1) = 1.82, p = .18
Participants (In-/Outpatient) 7/7 4/9 X2(N=27, df = 1) = 0.93, p = .34MarchTABLE 1 | Overview of use and use of the questionnaires.
Questionnaires Prestart Start Study-end Follow-up
SCID-I X
Informed Consent X
Sociodemographics X
Hamilton 24 X X X X
Becks Depression Inventory X X X
Work Ability Index X X X
Return to Work X X X
Insomnia Severity Index X X XPrestart = initial consultation, SCID-I, Structured Clinical Interview DSM-IV.2020 | Volume 11 | Article 168
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Work-Related Interpersonal Psychotherapy
The W-IPT condition followed a guideline (51, manuscript in
preparation). W-IPT focuses on the work context by adding
specific elements to the regular IPT strategies: identifying
work-related stress factors using an individual stress and
resource profile, creating a balance between performance
values and interpersonal values, teaching mindfulness and
coping strategies for work-related stress (including social
support), and practicing social communication skills at work
to cope with conflict and role changes. By applying those
strategies, we address social and interpersonal problems at
work, such as mobbing, interpersonal conflicts, role
transition, role confusion, burnout, boreout, job strain, low
social support, and work–life imbalance (for more details, see
Table 3). The intervention includes one weekly group session
of 90 min for six to eighr participants over 8 weeks in addition
to the TAU condition. Trained psychotherapists, certified in
IPT treatment, conducted the group sessions.
TAU Condition
The participants randomized to the TAU condition received no
further intervention during the study period and were
encouraged to continue with attending appointments with
their clinicians. In order to compensate for non-participation
in the W-IPT condition, the patients in the TAU condition were
offered to participate in the W-IPT program after their follow-
up evaluation.
Statistical Analysis
Following Julious (52), a caseload of 12 individuals per group
in pilot studies is reasonable to start with. A series of t-tests
and Pearson's correlations was performed to compare socio-
demographic, workplace-related, depression-related, and
sleep complaints information between the two groups.
To assess changes over time and between and within the
two groups, a series of ANOVAs for repeated measures was
performed with the factors time (start, study end, and follow-
up), group (intervention and TAU), and the time by groupFrontiers in Psychiatry | www.frontiersin.org 5interaction and with symptoms of depression (experts' ratings
and self-ratings), work-related information, and subjective
sleep complaints as dependent variables. Due to the
deviation of sphericity, the ANOVAs were performed using
Greenhouse–Geisser corrected degrees of freedom, although
the original degrees of freedom are reported with the relevant
Greenhouse–Geisser epsilon value (ϵ). All computations were
performed with the intention-to-treat analysis, with the last
observation carried forward method. For ANOVAs, the
effect sizes were reported as partial eta squared (hp2), with
0.01 < hp2 < 0.059 indicating small (S), 0.06 < hp2 < 0.139
indicating medium (M), and hp2 > 0.14 indicating large (L)
effect sizes. In addition, we followed Becker (53) and reported
effect sizes for t-tests within and between the groups for all
time points. To classify the effect sizes, we followed Cohen
(54): effect sizes can be evaluated as trivial (T; d = 0–0.19),
small (S; d = 0.20–0.49), medium (M; d = 0.50–0.79), or large
(L; d = 0.80 and greater). The level of significance was set at
alpha p ≤.05. All statistical calculations were performed with
SPSS® 25.0 (IBM Corporation, Armonk, NY, USA)
for Windows®.RESULTS
All descriptive, inferential, and statistical indices are reported in
Tables 4–6, and Figure 2. Table 4 shows the descriptive
statistics, Table 5 shows the inference statistics, Table 6 shows
the effect size comparisons, and Figure 2 shows the work
ability index.Symptoms of Depression: Experts’ Ratings
Experts' rated symptoms of depression decreased over time
(large effect size), but more so in the W-IPT group compared
to the TAU condition (medium effect size). Experts' rated
symptoms of depression was lower in the W-IPT group
(medium effect size). Within the W-IPT group, the
symptoms of depression decreased from baseline to the endTABLE 3 | Content of the sessions on workplace-related interpersonal psychotherapy.
Sessions Content of sessions
One Introducing members, identify work-related stress and dysbalances in the context of depression, theory and information, mindfulness exercise,
providing handouts and homework
Two Reflecting and discussing the homework, thoughts and feelings, introduction to self-care and mindfulness, role play exercise, and quick meditation,
providing handouts and homework
Three Reviewing homework, interpersonal stress and conflicts, introducing the Kiesler circle model, role play exercise, do not fall victim, mindfulness
meditation, providing handouts and homework
Four Staying in the present, mindfulness exercise of the body scan, communication at the workplace, how to solve conflicts at the workplace (using the
Kiesler model), discussing the homework, providing handouts and homework
Five Reflecting and discussing the homework, define and identify the living values, handout and discussion of what's important to me, building a
supportive network, work–life balance, self-compassion exercise, providing handouts and homework
Six Mindfulness exercise, reviewing the homework, role play, to ask for help, providing handouts and homework
Seven Mindfulness exercise, implementation of the values at the workplace, change and acceptance, providing handouts and homework
Eight Reviewing and discussion of the homework, balance between acceptance and change, applying what was learned, conducting a survey of the
course, conclusion and finishing the course along with last contemplationMarch 2020 | Volume 11 | Article 168
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(large effect size); from the end of the study to follow-up, the
symptoms of depression remained stably low (trivial effect
size). Within the TAU group, the symptoms of depression
decreased from baseline to the end of the study (small effect
size) and from baseline to follow-up (small effect size); from
the end of the study to follow-up, the symptoms of depression
remained stably low (trivial effect size).
Symptoms of Depression: Self-Ratings
The self-rated symptoms of depression decreased in both
groups over time (large effect size), but in the W-IPT group,
the symptoms of depression decreased more compared toFrontiers in Psychiatry | www.frontiersin.org 6those of the TAU condition (small effect size). The self-rated
symptoms of depression were lower in the W-IPT group
(medium effect size). Within the W-IPT group, the
symptoms of depression decreased from baseline to the end
of the study (large effect size) and from baseline to follow-up
(large effect size); from the end of the study to follow-up, the
symptoms of depression remained stably low (trivial effect
size). Within the TAU group, the symptoms of depression
decreased slightly from baseline to the end of the study (small
effect size) and from baseline to follow-up (medium
effect size); from the end of the study to follow-up, the
symptoms of depression remained stably high (trivial
effect size).TABLE 5 | Inferential statistics of depression, work, and sleep, with the factors Time (start, study-end & follow-up), Group (intervention vs. TAU), and the Time × Group
interaction.
Factors
Time Group Time × Group Greenhouse–Geisser
F hp2 F hp2 F hp2 Epsilon
Hamilton 24 12.048*** 0.325 [L] 1.610 0.060 [M] 1.618 0.061 [M] .995
Becks Depression Inventory 15.083*** 0.376 [L] 1.674 0.063 [M] 0.133 0.005 [S] .854
Work Ability Index 3.904* 0.135 [M] 4.981* 0.166 [L] 2.159 0.079 [M] .976
Return to Work 3.120 0.111 [M] 1.843 0.069 [M] 2.571 0.093 [M] .955
Insomnia Severity Index 12.616*** 0.335 [L] 2.676 0.097 [M] 3.032 0.108 [M] .706March 2020 | VDegrees of freedom—Time: (2, 25), Group: (1, 25), Time × Group (1, 25). S, small effect size; M, medium effect size; L, large effect size. S > 0.01, M > 0.06, L < 0.14. *p < 0.05; ***p < 0.001.TABLE 6 | Effect sizes for mean comparisons form pre- to post-assessment within the groups (intervention group and TAU group).
Group Start to study-end Start to follow-up Study-end to follow-up
W-IPT TAU W-IPT TAU W-IPT TAU
Cohen's d Cohen's d Cohen's d Cohen's d Cohen's d Cohen's d
Hamilton 24 1.246 [L] 0.255 [S] 1.115 [L] 0.381 [S] 0.007 [T] 0.096 [T]
Becks Depression Inventory 0.940 [L] 0.484 [S] 0.878 [L] 0.597 [M] 0.044 [T] 0.082 [T]
Work Ability Index 0.680 [M] 0.165 [S] 0.658 [M] 0.111 [T] 0.315 [S] 0.055 [T]
Return to Work 0.569 [M] 0.099 [S] 0.671 [M] 0.081 [T] 0.157 [T] 0.174 [T]
Insomnia Severity Index 1.145 [L] 0.212 [S] 1.177 [L] 0.382 [S] 0.179 [T] 0.150 [T]olume 11T, trivial effect size; S, small effect size; M, medium effect size; L, large effect size.TABLE 4 | Descriptive overview of the descriptive statistics, separately for assessment time (start, study-end, and follow-up) and group (W-IPT vs. TAU condition).
Assessment times
Baseline Study-end (+ 8 weeks) Follow-up (Total of 20 weeks)
W-IPT (N=14) TAU (N=13) W-IPT TAU W-IPT TAU
M (SD) M (SD) M (SD) M (SD) M (SD) M (SD)
Hamilton 24 25.5 (4.88) 27.46 (12.18) 16.36 (9.16) 23.85 (15.88) 16.29 (10.62) 22.39 (14.38)
Becks Depression Inventory 24.07 (8.11) 28.23 (12.23) 16.14 (8.74) 21.92 (13.81) 15.71 (10.74) 20.85 (12.50)
Work Ability Index 27.14 (10.48) 26.58 (7.80) 30.64 (10.12) 28.08 (10.22) 33.75 (9.58) 27.54 (9.50)
Return to Work 28.21 (5.22) 27.62 (6.23) 31 (4.56) 27 (6.30) 31.79 (5.45) 28.15 (6.89)
Insomnia Severity Index 14 (5.19) 14.67 (5.71) 8.64 (4.11) 13.31 (7.25) 7.79 (5.37) 12.23 (7.11)| Article 168
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The self-rated ability to work increased in both groups over
time (medium effect size), but in the W-IPT group, the
participants reported a higher self-rated ability to work
compared to the TAU condition (medium effect size). The
self-rated ability to work was higher in the W-IPT group
(large effect size). Within the W-IPT group, the self-rated
ability to work increased from baseline to the end of the study
(medium effect size) and from baseline to follow-up (medium
effect size); from the end of the study to follow-up, the ability
to work remained stably low (small effect size). Within the
TAU group, the self-rated ability to work increased slightly
from baseline to the end of the study (small effect size) and
from baseline to follow-up (trivial effect size); from the end of
the study to follow-up, the ability to work remained stably low
(trivial effect size) (cf. Figure 2).Return to Work: Self-Efficacy, Self-Ratings
The self-rated return to work increased in both groups over
time (medium effect size), but in the W-IPT group, the self-
rated return to work self-efficacy increased more compared to
the TAU condition (medium effect size). The self-rated return
to work was higher in the W-IPT group (medium effect size).
Within the W-IPT group, the self-rated return to work
increased from baseline to the end of the study (medium
effect size) and from baseline to follow-up (medium effect
size); from the end of the study to follow-up, return to work
remained stably high (trivial effect size). Within the TAU
group, the self-rated return to work increased slightly fromFrontiers in Psychiatry | www.frontiersin.org 7baseline to the end of the study (small effect size) and from
baseline to follow-up (trivial effect size); from the end of the
study to follow-up, return to work remained stably low (trivial
effect size).Subjective Sleep Quality
Insomnia Severity Index: Self-Ratings
The self-rated sleep complaints decreased in both groups
over time (large effect size), but more so in the W-IPT group
compared to the TAU condition (medium effect size). The
self-rated sleep complaints were lower in the W-IPT group
(medium effect size). Within the W-IPT group, the self-rated
sleep complaints decreased from baseline to the end of the
study (large effect size) and from baseline to follow-up (large
effect size); from the end of the study to follow-up, the self-
rated sleep complaints remained stably low (trivial effect
size) . Within the TAU group, the self-rated sleep
complaints decreased only slightly from baseline to the end
of the study (small effect size) and from baseline to follow-up
(small effect size); from the end of the study to follow-up, the
self-rated sleep complaints remained stably high (trivial
effect size)
To summarize, the symptoms of depression (experts'
rating) decreased in both groups over time (large effect
sizes), but in the W-IPT group, the symptoms of depression
decreased more compared to those of the TAU group. The
reduction at follow-up led the W-IPT group to an altered
assessment of the severity of the depression diagnosis (from
moderate to mild), whereas in the TAU condition theFIGURE 2 | Work Ability Index (WAI).March 2020 | Volume 11 | Article 168
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symptoms of depression (self-rating) decreased in both
groups over time (large effect sizes), but in the W-IPT, the
symptoms of depression decreased more compared to those of
the TAU group. The work abi l i ty index self-rated
interpretation gained in both groups over time (medium
effect size), but in the W-IPT, the work ability increased
more compared to that of the TAU group. The self-efficacy
for the return to work gained in both groups over time
(medium effect size), but in the W-IPT, the self-efficacy
increased more compared to that of the TAU group. The
self-rated symptoms of subjective sleep complaints decreased
in both groups over time (large effect size), but in the W-IPT
group, the sleep complaints decreased more compared to
those of the TAU.DISCUSSION
The key findings of the present study suggest that a specific
work-related approach for depressed patients with work stress
led to a greater decrease of clinician- and self-rated depressive
symptoms compared to TAU. In addition, not only the
subjective work ability was higher and the self-efficacy was
more improved in the W-IPT group but also the quality of
sleep was more increased compared to the TAU condition.
Importantly, those effects remained stable over the follow-up
time period. The particularly large effect in the W-IPT
condition indicates that a job-related focus can help in the
short and long terms.
The present study adds to the current literature in an important
way because not only is the IPT beneficial for individuals withMDD
(31, 55) but also it is especially based on psychosocial and
workplace-related issues [see also Schramm and Berger (32)]. Our
main study strength is the value of longitudinal research for
extending knowledge about the relationship between W-IPT and
MDD because of workplace-related stress.
The results are important for clinicians because the newest
meta-analysis (8) showed that it is unclear whether the
antidepressive treatment is more efficacious than the placebo
treatment. There is an obvious necessity to use best evidence-
based practices. The psychotherapeutic treatments are well
evaluated, especially the cognitive–behavioral aspect, and IPT
seems to be the preferred choice. The present study results are
in line with the results shown before.
To summarize, all of our hypotheses plus the exploratory
research question were fully confirmed. In this respect, comparing
the effect of the intervention with those of the previous studies (see
“Introduction”), again we hold that the present finding is clinically
relevant. Thus, the present finding is in accord with previous results
(33–35). We believe that the beneficial influence of W-IPT cannot
be explained merely as an effect of time as they outperformed the
outcome of the TAU condition.
In terms of comparing the long-term effect sizes of the present
study with those of the previous studies, the present finding is in
accord with previous results (37, 38).Frontiers in Psychiatry | www.frontiersin.org 8We expected the work ability in the intervention group to be
higher than in the TAU group. Surprisingly, the work ability in
the W-IPT condition grew further even after the end of the study
and over the follow-up time from originally poor to medium at
the end of the intervention and almost good at follow-up, while
the TAU condition showed a stable trend of poor work ability.
Despite the intriguing findings, several limitations warrant
against overgeneralization of the present results. First, the
sample size was small, although we basically relied on effect
size calculations which, unlike p-values, do not vary with
sample size, but since this was a pilot study, the small
numbers can be explained. Further, there are increasing
concerns about the importance and ‘significance' of p-values
(56). Second, the sample with a broad age range can be seen
not only as a possible limitation but also as a strong point.
After all , there was a positive influence despite the
heterogeneity of the sample.
Further studies might differentiate between specific groups (f.i.,
gender, age, or comorbidities). Another limitation is the relative
short follow-up period of 3 months. A longer follow-up could be
helpful, especially in practical uses (employee training). Booster
sessions could be provided to ensure sustainable effects. In addition,
our study compared the possible effect of a new group programwith
a TAU condition. We cannot definitively say whether or not it is
superior to other evidence-supported psychological treatments such
as cognitive behavioral therapy. Furthermore, the inclusion and
exclusion criteria were chosen to identify a particular kind of
sample. However, comorbidities such as substance use or
personality disorders are common in depressive disorders. Lastly,
it is possible that further latent but unassessed variables (family
members, sleep–quality interaction, and increase in social support)
might have biased the results shown (in any given
direction possible).CONCLUSIONS
An 8-week group intervention with W-IPT had improved
symptoms of depression, ability to work, self-efficacy regarding
return to work, and sleep complaints more than the TAU condition.
We believe that the present results might be of broader
interest: First, in terms of the costs for the companies (hiring
new employee and absent or less productive employees) and
for the employees (health and changing the job). Specifically,
costs in employees being less productive or absent will result
in several high costs per employee (26, 27, 30, 57). Second, the
public health cost should also be mentioned here although we
did not calculate the costs. Third, it follows that the benefit of
an early investment in individual health should be the main
interest of all three partners.
A short efficient treatment in groups seems to be easy to
implement and economical. It could be a fixed part of a regular
occupational health management (58, 59). The possible uses are (1)
companies interested in having a modern occupational health
management and (2) individuals experiencing stress and
problems at the workplace for secondary or tertiary prevention.March 2020 | Volume 11 | Article 168
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